Sentinel node biopsy in breast cancer

Breast

Volumn 9, Issue 3, 2000, Pages 139-143

  Zavagno, G ^a   Busolin, R ^b   Bozza, F ^c   Ramuseello, S ^d   Griggio, L ^e   Montesco, M C ^a   Valsecchi, M ^b   Capitanio, G ^d   Casara, D ^c   Dalla Pozza, S ^b   Bonazza, A ^d   Rossi, C R ^a   Meggiolara, F ^a   Lise, M ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Azienda Ospedaliera di Mestre   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d Azienda Ospedaliera   (Italy)

^e Azienda Ospedaliera di Dolo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN TC 99M; ALBURES; NANOCOLL TC 99M;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL TRIAL; HISTOPATHOLOGY; HUMAN; LYMPH NODE; LYMPH NODE BIOPSY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENTINEL LYMPH NODE;

EID: 19244380702     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2000.0169     Document Type: Article

References (17)

1. Veronesi U, Luini A, Galimberti V. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol. 16:1990;127-133.
2. Cabanas R M. An approach for the treatment of penile carcinoma. Cancer. 39:1977;456-466.
3. Leong S P, Steinmetz I, Habib F A. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg. 132:1997;666-672.
4. Pijpers R, Borgstein P J, Meijer S. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg. 21:1997;788-792.
5. Veronesi U, Paganelli G, Viale G. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Nat Cancer Inst. 91:1999;368-373.
6. Koller M, Barsuk D, Zippel D. Sentinel lymph node involvement, a predictor for axillary node status with breast cancer, has the time come. Eur J Surg Oncol. 24:1998;166-168.
7. Borgstein P J, Pijpers R, Comans E F. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg. 186:1998;275-283.
8. Giuliano A E. Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection (editorial). J Surg Oncol. 62:1996;75-77.
9. Eltson C W, Ellis I O. Pathological prognostic factors in breast cancer: experience from a large study with long term follow-up. Histopathology. 19:1996;403-410.
10. Wilhelm A J, Mijnhout G S, Franssen E J F. Radiopharmaceuticals in sentinel lymphnode detection. An overview. Eur J Nucl Med. 26:1999;S36-S42.
11. Nieweg O E, Jansen L, Valdés Olmos R A. Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med. 26:1999;S11-S16.
12. Borgstein P J, Meijer S, Pijpers R. Intradermal blu dye to identify sentinel lymph node in breast cancer. Lancet. 349:1997;1668-1669.
13. O'Hea B J, Hill A D K, El-Shirbiny A M. Sentinel Lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg. 186:1998;423-427.
14. Roumen R M H, Valkenburg J G M, Geuskens L M. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol. 23:1997;495-502.
15. Van Diest, P, J, Peterse, H, L, Borgstein, P, J, Pathological investigation of sentinel lymph nodes, Eur J Nucl Med, 26, S43, S49.
16. Turner R R, Ollila D W, Krasne D L, Giuliano A E. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg. 226:1997;271-278.
17. Reintgen D. What is the role and impact of the sentinel node sampling technique in breast cancer staging? Cancer Control: JMCC. 4:1997;5-8.